A cloud-based application that allows a provider to request a brand name medication for a patient when deemed “Medically Necessary” and then document the adverse effect related to the generic equivalent at the same time. Infina Connect’s BRANDS registry implements a NC Medicaid policy requiring prescribers of certain brand drugs to document the medical necessity of dispensing the brand drug “as written” rather than allowing substitution of a generic equivalent.
Through our BRANDS registry, prescribers can easily submit the required information, which follows closely the information that the FDA requests on its Medwatch form for reporting adverse drug events. Complete documentation generates an immediate authorization that remains on file indefinitely for the patient. The information is available to the prescriber at any time for reference and download, to the health plan for population health management, and relevant adverse events can be transmitted electronically to the FDA’s MedWatch program.
As the newest PDM solution for NC Medicaid, first-year savings are not available for BRANDS but are expected to be in line with the savings from our other PDM solutions.